Bone metastases from differentiated thyroid carcinoma: heterogenous tumor response to radioactive Iodine therapy and overall survival
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1619-7089
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Bone metastases from differentiated thyroid carcinoma: heterogenous tumor response to radioactive Iodine therapy and overall survival ; day:12 ; month:2 ; year:2022 ; pages:1-13
European journal of nuclear medicine and molecular imaging ; (12.2.2022), 1-13
- Urheber
-
Jannin, Arnaud
Lamartina, Livia
Moutarde, Coralie
Djennaoui, Mehdi
Lion, George
Chevalier, Benjamin
Vantyghem, Marie Christine
Deschamps, Frédéric
Hadoux, Julien
Baudin, Eric
Schlumberger, Martin
Leboulleux, Sophie
Cao, Christine Do
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00259-022-05697-w
- URN
-
urn:nbn:de:101:1-2022051818443700790017
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 15.08.2025, 07:27 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Jannin, Arnaud
- Lamartina, Livia
- Moutarde, Coralie
- Djennaoui, Mehdi
- Lion, George
- Chevalier, Benjamin
- Vantyghem, Marie Christine
- Deschamps, Frédéric
- Hadoux, Julien
- Baudin, Eric
- Schlumberger, Martin
- Leboulleux, Sophie
- Cao, Christine Do
- SpringerLink (Online service)
Ähnliche Objekte (12)
Predictive Factors of Radioactive Iodine Therapy Refractoriness in Patients with Differentiated Thyroid Carcinoma
Causes of False-Positive Radioactive Iodine Uptake in Patients with Differentiated Thyroid Cancer
Risk and outcome of subsequent malignancies after radioactive iodine treatment in differentiated thyroid cancer patients
Myxedema Psychosis after Levothyroxine Withdrawal in Radioactive Iodine Treatment of Differentiated Thyroid Cancer: A Case Report
How Radioactive Iodine Treatment Affects the Retina
Can 18F-fluorodeoxyglucose positron emission tomography predict the response to radioactive iodine therapy in metastatic differentiated thyroid carcinoma?
Radioactive Body Burden Measurements in 131 Iodine Therapy for Differentiated Thyroid Cancer: Effect of Recombinant Thyroid Stimulating Hormone in Whole Body 131 Iodine Clearance
68Ga-PSMA PET/CT in radioactive iodine-refractory differentiated thyroid cancer and first treatment results with 177Lu-PSMA-617
Graves’ Disease-Related Pancytopenia Improved after Radioactive Iodine Ablation
Second primary malignancies induced by radioactive iodine treatment of differentiated thyroid carcinoma — a critical review and evaluation of the existing evidence
Levothyroxine-induced serum free thyroxine response following radioactive iodine administration in patients thyroidectomized for differentiated thyroid cancer: A randomized controlled trial
Change in BMI after radioactive iodine ablation for graves disease
Predictive Factors of Radioactive Iodine Therapy Refractoriness in Patients with Differentiated Thyroid Carcinoma
Causes of False-Positive Radioactive Iodine Uptake in Patients with Differentiated Thyroid Cancer
Risk and outcome of subsequent malignancies after radioactive iodine treatment in differentiated thyroid cancer patients
Myxedema Psychosis after Levothyroxine Withdrawal in Radioactive Iodine Treatment of Differentiated Thyroid Cancer: A Case Report
How Radioactive Iodine Treatment Affects the Retina
Can 18F-fluorodeoxyglucose positron emission tomography predict the response to radioactive iodine therapy in metastatic differentiated thyroid carcinoma?
Radioactive Body Burden Measurements in 131 Iodine Therapy for Differentiated Thyroid Cancer: Effect of Recombinant Thyroid Stimulating Hormone in Whole Body 131 Iodine Clearance
68Ga-PSMA PET/CT in radioactive iodine-refractory differentiated thyroid cancer and first treatment results with 177Lu-PSMA-617
Graves’ Disease-Related Pancytopenia Improved after Radioactive Iodine Ablation
Second primary malignancies induced by radioactive iodine treatment of differentiated thyroid carcinoma — a critical review and evaluation of the existing evidence
Levothyroxine-induced serum free thyroxine response following radioactive iodine administration in patients thyroidectomized for differentiated thyroid cancer: A randomized controlled trial
Change in BMI after radioactive iodine ablation for graves disease
Predictive Factors of Radioactive Iodine Therapy Refractoriness in Patients with Differentiated Thyroid Carcinoma
Causes of False-Positive Radioactive Iodine Uptake in Patients with Differentiated Thyroid Cancer
Risk and outcome of subsequent malignancies after radioactive iodine treatment in differentiated thyroid cancer patients
Myxedema Psychosis after Levothyroxine Withdrawal in Radioactive Iodine Treatment of Differentiated Thyroid Cancer: A Case Report
How Radioactive Iodine Treatment Affects the Retina
Can 18F-fluorodeoxyglucose positron emission tomography predict the response to radioactive iodine therapy in metastatic differentiated thyroid carcinoma?
Radioactive Body Burden Measurements in 131 Iodine Therapy for Differentiated Thyroid Cancer: Effect of Recombinant Thyroid Stimulating Hormone in Whole Body 131 Iodine Clearance
68Ga-PSMA PET/CT in radioactive iodine-refractory differentiated thyroid cancer and first treatment results with 177Lu-PSMA-617
Graves’ Disease-Related Pancytopenia Improved after Radioactive Iodine Ablation
Second primary malignancies induced by radioactive iodine treatment of differentiated thyroid carcinoma — a critical review and evaluation of the existing evidence
Levothyroxine-induced serum free thyroxine response following radioactive iodine administration in patients thyroidectomized for differentiated thyroid cancer: A randomized controlled trial